133 studies found for:    "juvenile idiopathic arthritis" OR "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
21 Recruiting An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
22 Recruiting Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Leflunomide
23 Unknown  Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: etanercept
24 Recruiting Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: Web-based coping skills training;   Behavioral: Online disease education
25 Recruiting Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: 800 mg ibuprofen/26.6 mg famotidine
26 Recruiting A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
27 Not yet recruiting Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: methotrexate prefilled pen
28 Completed Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis;   Still Disease, Juvenile-Onset
Intervention: Drug: Genotropin
29 Recruiting Extension Study Evaluating the Safety and Efficacy of Subcutaneous RoActemra/Actemra Administration in Patients With Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra]
30 Recruiting A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
31 Completed
Has Results
A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Tocilizumab;   Drug: Placebo
32 Completed Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
Conditions: Uveitis;   Juvenile Idiopathic Arthritis
Intervention: Drug: Cyclosporine A
33 Unknown  Magnetic Resonance Imaging Follow-up on Temporomandibular Arthritis in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: Steroid injection into the TMJs.
34 Recruiting Long-Term Safety Study Of CP-690,550 In Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550
35 Completed An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: RoActemra/Actemra (tocilizumab)
36 Recruiting Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Conditions: Uveitis;   Juvenile Arthritis
Interventions: Drug: Anti-tumor necrosis factor alpha monoclonal antibody;   Drug: placebo
37 Recruiting Virtual Peer-to-Peer (VP2P) Support Mentoring for Juvenile Idiopathic Arthritis (JIA): A Pilot RCT
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: Virtual Peer-to-Peer Support Mentoring
38 Recruiting Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550
39 Active, not recruiting
Has Results
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra];   Drug: Placebo;   Drug: Non-steroidal anti-inflammatory drugs (NSAIDs);   Drug: methotrexate;   Drug: corticosteroids
40 Completed A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years